Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVP-0962 in healthy subjects and early Alzheimer's disease
NCT01661673Phase 2Completed
- Sponsor
- FORUM Pharmaceuticals
- Start
- Nov 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EVP-0962 in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by FORUM Pharmaceuticals. Started Nov 2012; status: completed.
02
Drugs
EVP-0962
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01661673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01661673.